Territory: NC, SC, GA, FL

Provide clinical and research support across Fresenius' portfolio of pharmaceuticals and medical devices for patients with kidney diseaseDisease states: hyperphosphatemia, anemia, CKD-associated pruritus, fluid management, in-center hemodialysis, home hemodialysis, peritoneal dialysis, critical careTerritory: Texas, Louisiana, Oklahoma

Supported development of novel therapies for hyperphosphatemia and hyperkalemia in end-stage renal disease patients

Supported development of novel therapy (difelikefalin) for treatment of chronic kidney disease-associated pruritus

• Renal Medical Science Liaison supporting pharmaceuticals and medical devices• Territory: Colorado, Montana, Idaho, Washington, Oregon, Northern California, Alaska• 2019 Medical Science Liaison of the Year Award

Kidney Research• Awarded NIH Fellowship in Pediatric Nephrology (2017-2018)• Collaborated with physicians to identify clinically relevant research questions and establish studies • Investigated the role of FGF23 in chronic kidney disease (CKD), mineral bone disorder (MBD), and cardiovascular disease (CVD)Drug Development | Cardiovascular Research:• Awarded NIH R01 Grant as Co-Investigator to investigate the role of gut microbiome in atherosclerosis• Partnered with Cleveland Clinic on drug development collaboration yielding novel cardiovascular therapeutics that target pathogenic gut microbiotaScience Communication:• Invited speaker on "The Academic Minute" (Northeast Public Radio)• Disseminated research findings to the public through international media networks• Published review of gut microbiome's role in atherosclerosis in Nature Reviews Cardiology

Team Management:• Aligned teams from Texas A&M, UNC, Johns Hopkins, and University of Tennessee to efficiently analyze data, interpret results, and produce publications, posters, and slide decksScience Communication:• Authored a Genetics research article, which ranks top 10 all-time for public attention, investigating genome by diet interactions influencing cardiometabolic risk factors• Shared research findings via media interviews published across 100+ media outlets worldwide.• Awarded “Outstanding Presentation” at 2016 Allied Genetics ConferenceMentorship:• Mentored 16 students on independent research projects while at Texas A&M• Advised 6 students on senior thesis projects• Mentees won presentation awards at three local and national conferences

Cardiometabolic Research:• Headed investigation involving 25+ scientists that modeled genome-based dietary recommendations in preclinical cardiometabolic trials.• Developed animal models to investigate cardiovascular disease susceptibility genes.• Research led to award of $5 million NIH RM1 multidisciplinary grantOncology Research:• Determined influence of genetics on colorectal cancer risk under varying dietary conditions.• Identified role of gut bacteria in colorectal cancer susceptibility.• Instructed workshop on mouse models of human cancers at The Jackson LaboratoryWomen's Health Research:• Identified novel biomarkers of ovarian aging in preclinical studies and validated findings in clinical cohorts in a research partnership with the University of Sannio.Science Communication: • Delivered 25+ presentations at regional and international conferences, and discussed research findings in one-on-one and small group discussions with KOLs.• Awarded "Best Graduate Presentation" at Texas Genetics Society Conference.

Oncology Research:• Investigated genetic modifiers of the PTEN tumor-suppressor gene by QTL mapping in mice• Designed and managed preclinical trials on precision medicine for colorectal cancer prevention

• Coordinated collaborative research trials with industry partners in a timely, ethical, customer-focused manner that generated $250,000 in funding. • Collected, analyzed, and maintained data in compliance with study protocols and federal regulations.